BTMD
BTMD
NASDAQ · Pharmaceuticals

Biote Corp -A

$2.26
-0.01 (-0.44%)
As of Jun 21, 10:40 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 2 18%
Sell 0 0%
Price Target
Analyst Price Target +639.4% upside
Low Target $12.81
Average Target $16.71
High Target $20.08
Current Price $2.26
Current
$2.26
Target
$16.71
$12.81 $16.71 avg $20.08
Scenario Analysis
Bear Case
$12.81
466.8%
Low target
Base Case
$16.71
+639.4%
Avg target
Bull Case
$20.08
+788.5%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$4.75
-52.4% from high
52-Week Low
$1.27
+78.0% from low
Target vs 52W High
$16.71
+251.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%